glp 1 semaglutide or tirzepatide & are transforming diabetes & obesity management. These GLP-1 receptor agonists offer benefits from glycemic control to weight loss and cardiovascular risk reduction, emphasizing their broad impact. Read more from GLP-1 vs. GLP-1 + GIP:

Exploring the role of goal setting in weight loss for adults recently diagnosed with pre-diabetes

Biomarker profiling can help contextualize whether GLP-1 therapy aligns with your metabolic phenotype

The flexible linker ensures spatial separation between the Fc region and the GLP-1 receptorbinding domain, preserving receptor accessibility and bioactivity

The analysis employed a robust causal inference framework, multiple analytic strategies under an FMA framework, and extensive sensitivity analyses such as principal stratification and E-value estimation

No studies have specifically looked at combining them, but given Pycnogenols safety, its likely fine